bs-2044R-Cy3 [Conjugated Primary Antibody]
LOX 1 Polyclonal Antibody, Cy3 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: LOX 1

Immunogen Range: 201-273/273


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 100009322

Swiss Prot: Q9XTA8

Source: KLH conjugated synthetic peptide derived from Rabbit LOX-1

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria (By similarity).

Conjugation: Cy3

Excitation/ Emission: 512,550nm/570,615nm

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
FCM(1:20-100)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 31/50


Cross Reactive Species: Human
Mouse
Rat
Rabbit

Predicted Cross Reactive Species: Cow

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Deng, Zu Yue, et al. "Resveratrol alleviates vascular inflammatory injury by inhibiting inflammasome activation in rats with hypercholesterolemia and vitamin D2 treatment." Inflammation Research: 1-12.Read more>>
  • Li, Cui, et al. "The Role of LOX-1 in Innate Immunity to Aspergillus fumigatus in Corneal Epithelial CellsLOX-1 in Corneal Epithelium to Fungal Infection." Investigative Ophthalmology & Visual Science 56.6 (2015): 3593-3603.Read more>>
  • Gao, Xinran, et al. "LOX-1 and TLR4 affect each other and regulate the generation of ROS in A. fumigatus keratitis." International Immunopharmacology 40 (2016): 392-399.Read more>>
  • Shibata, Masa-Aki, et al. "Pathological and molecular analyses of atherosclerotic lesions in ApoE-knockout mice." Medical Molecular Morphology: 1-15.Read more>>
  • Song Q et al. Potential mechanisms underlying the protective effects of salvianic acid A against atherosclerosis in vivo and vitro. (2019)Biomedicine & Pharmacotherapy, 109, 945–956. Read more>>
  • Yang B et al. Polychlorinated Biphenyl Quinone Promotes Macrophage-Derived Foam Cells Formation. Chem Res Toxicol. 2019 Nov 13. Read more>>
  • Gao X et al. Inhibition of LOX-1 prevents inflammation and photoreceptor cell death in retinal degeneration. Int Immunopharmacol. 2020 Mar;80:106190. Read more>>
  • Qian Liet al. LOX-1 Regulates P. gingivalis-Induced Monocyte Migration and Adhesion to Human Umbilical Vein Endothelial Cells. Front Cell Dev Biol. 2020 Jul 14;8:596.Read more>>
  • Sato, Kayoko. et al. Oxidative stress-responsive apoptosis-inducing protein in patients with heterozygous familial hypercholesterolemia. 2021 Jul 26Read more>>
  • Tingting Hao. et al. Phosphatidylethanolamine alleviates OX-LDL-induced macrophage inflammation by upregulating autophagy and inhibiting NLRP1 inflammasome activation. FREE RADICAL BIO MED. 2023 Nov;208:402Read more>>
VALIDATION IMAGES